Connect with us

Hi, what are you looking for?

AI Technology

Vector-Borne Disease Surveillance AI Market to Reach $4.01 Billion by 2030 with 20.2% CAGR

Vector-borne disease surveillance AI market set to hit $4.01 billion by 2030, growing at 20.2% CAGR, driven by innovations from Amazon and Microsoft.

The vector-borne disease surveillance artificial intelligence (AI) market is poised for significant growth, driven by an increasing need for effective public health monitoring and outbreak response strategies. By 2030, the market is projected to reach a valuation of $4.01 billion, reflecting a compound annual growth rate (CAGR) of 20.2%. This expansion is attributed to various factors, including the rising demand for AI-powered epidemic forecasting, climate change resulting in the broader spread of disease vectors, and the emergence of smart surveillance technologies that enhance predictive public health planning.

As climate conditions evolve, the integration of AI into vector-borne disease surveillance systems becomes crucial. Key trends shaping this market include the development of AI-driven outbreak prediction models, vector risk mapping aligned with climate data, automated species identification, real-time epidemiological dashboards, and comprehensive surveillance platforms that aggregate data from various sources. Such advancements are vital for efficiently managing diseases like malaria, dengue, and Zika virus as global health challenges intensify.

Leading firms in the vector-borne disease surveillance AI sector include Amazon Web Services Inc., Microsoft Corporation, IBM, and Siemens Healthineers AG, among others. These organizations are heavily investing in technological innovations, particularly in AI-driven real-time vector prediction systems that leverage Internet of Things (IoT) sensors for enhanced outbreak forecasting. Such systems not only track mosquito populations and species but also assess environmental factors and trigger alerts for targeted interventions, outpacing traditional surveillance methods.

A notable acquisition in this space occurred in June 2025 when bioMérieux, a French company specializing in in vitro diagnostic solutions, acquired assets from Day Zero Diagnostics. This strategic move aims to enhance bioMérieux’s capabilities in next-generation sequencing and machine learning, facilitating faster identification and antibiotic resistance profiling of pathogens. Day Zero Diagnostics, based in the U.S., offers machine learning-driven genome sequencing solutions that complement bioMérieux’s objectives of real-time pathogen monitoring.

Technological advancements are further illustrated by the recent launch of the Smart Mosquito Surveillance System (SMoSS) by the Andhra Pradesh Municipal Administration and Urban Development Department in India in July 2025. This AI-enabled platform provides real-time tracking of mosquito populations in urban regions particularly susceptible to vector-borne diseases. Utilizing smart sensors, traps, drones, and IoT infrastructure, SMoSS continuously collects field data and generates heat maps to highlight breeding and infestation hotspots, thereby aiding public health responses.

The vector-borne disease surveillance AI market is structured into several segments, including software, hardware, services, deployment modes, applications, and end-users. The software segment encompasses predictive analytics, data management, visualization, reporting, and geospatial mapping tools. Hardware includes sensors and detection devices, wearable monitoring units, surveillance cameras, and data storage solutions. Services range from consulting and implementation to maintenance, training, and integration. Such segmentation reflects the diverse technologies and deployment options that are driving the market forward globally.

As the global community grapples with the complexities of emerging health threats, the role of AI in vector-borne disease surveillance is set to become increasingly vital. With stakeholders across the public health and technology sectors investing in these innovative solutions, the potential for improved outbreak prediction and management represents a significant advancement in maintaining global health security.

See also
Staff
Written By

The AiPressa Staff team brings you comprehensive coverage of the artificial intelligence industry, including breaking news, research developments, business trends, and policy updates. Our mission is to keep you informed about the rapidly evolving world of AI technology.

You May Also Like

© 2025 AIPressa · Part of Buzzora Media · All rights reserved. This website provides general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information presented. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult appropriate experts when needed. We are not responsible for any loss or inconvenience resulting from the use of information on this site. Some images used on this website are generated with artificial intelligence and are illustrative in nature. They may not accurately represent the products, people, or events described in the articles.